Regeneron (REGN) Highlights Positive Topline Results in Phase 3 Trial
Go back to Regeneron (REGN) Highlights Positive Topline Results in Phase 3 Trial| Regeneron (NASDAQ: REGN) | Delayed: 789.45 +14.84 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $774.61 | 52 Week High | $592.36 | |||
| Open | $781.18 | 52 Week Low | $325.35 | |||
| Day High | $789.99 | P/E | 207.20 | |||
| Day Low | $774.78 | EPS | $3.81 | |||
| Volume | 702,808 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.14 +0.55 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.59 | 52 Week High | $44.76 | |||
| Open | $42.82 | 52 Week Low | $36.81 | |||
| Day High | $43.23 | P/E | N/A | |||
| Day Low | $42.82 | EPS | $0.00 | |||
| Volume | 2,955,730 | |||||
